[1] Schorge JO, Goldstein DP, Bemstein MR, et al. Recent advances in gestational trophoblastic disease [J]. J Reprod Med, 2000, 45(9):692-700. [2] 宋鸿钊.滋养细胞肿瘤的诊断与治疗[M].北京:人民卫生出版社,1983.168. [3] Mosher R, Goldstein DP, Berkowitz RS, et al. Complete hydatidiform mole: comparison of clinicopathologic features, current and past[J]. J Reprod Med, 1998, 43(1): 21-7. [4] Fisher RA, Nowland ES. Gestational trophoblastic disease molecular and genetic studies[J]. J Reprod Med, 1998, 43(2): 87-97. [5] Coukos G, Makrigiannakis A, Chung J, et al. Complete hydatidiformmole: adisease with changing profile[J]. J Reprod Med, 1999, 44(8): 698-704. [6] 曹泽毅. 中华妇产科学[M]. 第 4 版, 北京: 人民卫生出版社, 2002.2018-22. [7] Fromowitz FB, Viola MV, Chao S, et al. Ras, P21 expression in the progression of breast cancer [J]. Human Pathol, 1987, 18(42):1268-75. [8] Habibian R, Surti U. Cytogenetics of trophoblasts from complete hydatidiform moles [J]. Cancer Genet Cytogenet, 1987, 29(2): 271-87. [9] Nishio H, Nakamura S, Horai T, et al. Clinical and histopathologic evaluation of the expression of Ha-ras and fes oncogene products in lung cancer[J]. Cancer, 1992, 69(5): 1130-6. [10] Tanaka TS, Kunath T, Kimber WL, et al. Gene expression profiling of embryo derived stem cells reveals candidate genes associated with pluripotency and lineage specificity[J]. Genome Res, 2002, 12(12): 1921-8. [11] Bilban M, Head S, Desoye G, et al. DNA microarrays: a novel approach to investigate genomics in trophoblast invasion [J]. Placenta, 2000, 21(Suppl A): S99-105. [12] Leone A, McBirde OW, Weston A, et al. Somatic allelic deletion of nm23 in human cancer[J]. Cancer Res, 1991, 51(9): 2490-3. [13] McGregor JM, Yu CC, Dublin EA, et al. P53 immunoreactivity in human malignant melanoma and dysplastic naevi [J]. Br J Dermatol, 1993, 128(6): 606-11. [14] 乐杰.妇产科学[M].第6版,北京:人民卫生出版社,2004319-23. |